This bill establishes licensing and certification standards for tobacco treatment specialists in New Jersey. It creates two new credentials: "Certified tobacco treatment specialist" (requiring a high school diploma, 42-hour training, and experience) and "Licensed clinical tobacco treatment specialist" (requiring a master's degree, 18 graduate counseling hours, and a national exam). The law directly affects professionals providing tobacco/nicotine counseling by setting education, training, and examination requirements. It amends existing law to mirror standards already applied to alcohol/drug counselors, aiming to ensure qualified practitioners meet consistent standards for public safety.
This bill requires health insurance plans in New Jersey to cover specific treatments for lipedema, a chronic fat disorder. It mandates coverage for compression garments, manual lymphatic drainage, medical nutrition therapy, mental health care, and medically necessary lipectomies (including pre- and post-surgery appointments). Insurers must base coverage decisions on physician diagnoses and surgeon documentation (including photos for lipectomies), cannot deny coverage solely based on photos, and must honor prior authorizations for lipectomies for one year. The coverage must match the same deductibles, coinsurance, and standards of care as other similar medical treatments. This directly affects insured residents diagnosed with lipedema and their health insurance providers.
This bill, S 2996, eliminates physician collaboration requirements for advanced practice nurses (APNs) in New Jersey, allowing them to practice independently without supervision or joint protocols. It directly affects APNs - registered nurses with specialized training in primary and specialty care - and aims to improve healthcare access, particularly in underserved communities and for populations facing barriers like low income or transportation challenges. The key provision removes statutory restrictions that previously limited APNs' scope of practice, aligning New Jersey with 24 states that grant full practice authority. The bill cites pandemic-era waivers (Executive Order No. 112) that allowed similar independent practice without adverse incidents, and notes APNs could reduce healthcare access disparities by over 38% if restrictions are lifted.
This New Jersey bill establishes the "Privacy Protection Act" to limit how government agencies and healthcare facilities collect and share certain personal information. It prohibits them from requesting details like immigration status, citizenship, social security numbers, or tax IDs unless necessary for specific public services, benefits, or healthcare delivery (with healthcare exceptions for patient safety). The bill requires written consent in the person's preferred language for sharing any collected data, detailing exactly what will be shared, why, and confirming consent is voluntary without retaliation. It also bans selling or sharing vehicle license plate data except under court orders, subpoenas, or with explicit written consent, and mandates government entities to update privacy policies within one year.
This bill, "Anthony Maruca’s Law," requires New Jersey law enforcement officers who have access to epinephrine auto-injectors to complete approved training on emergency administration. It allows police departments to provide these devices to officers for use during official duties, storing them in vehicles or medical kits per health department guidelines. The law directly affects officers employed by police departments and mandates certification of training completion for those using the devices. Key provisions include the training requirement and authorization for departments to maintain the injectors, with no new funding or cost mandates specified.
S 3023 protects residents of long-term care facilities (like nursing homes and assisted living facilities) and long-term acute care hospitals by preventing facility staff, owners, or financially benefiting parties from managing residents' finances or serving as their legal representatives. It requires facilities to use standardized admission forms developed by the Department of Health, with input from stakeholders, and prohibits residents from signing non-standard documents during admission. The bill also gives residents a legal right to sue if facilities violate these protections, allowing recovery of damages, attorney fees, and punitive penalties for financial exploitation. These changes directly affect residents, their families, and facility operators by creating new safeguards against financial abuse during admission and care.
S 712 requires New Jersey's Department of State to create a public "Reproductive Health Travel Advisory" to help residents traveling while pregnant make informed decisions. The advisory will categorize all U.S. states using a color-coded system: "Blue" (full access without legal risk), "Yellow" (restricted access with potential legal consequences), and "Red" (extreme restrictions risking denial of emergency care). It will detail each state's laws on abortion bans, waiting periods, insurance coverage, and legal protections for patients and providers. The advisory must be posted on the state website and updated whenever another state changes its reproductive healthcare laws. This directly affects New Jersey residents who may need to travel during pregnancy for medical emergencies.
This bill requires health insurance companies and other health carriers in New Jersey to reimburse healthcare providers for vaccines at a rate no lower than the Centers for Disease Control and Prevention (CDC) cost per dose rate listed on the CDC's official price list. It directly affects health insurance carriers (including companies and health plans) and healthcare providers who administer vaccines. The key provision sets a minimum reimbursement rate based on the CDC's actual per-dose cost effective on the date the vaccine was provided. This ensures providers are paid at least the CDC's contracted price, preventing underpayment for vaccine administration.
S 1796 requires New Jersey health insurance plans to cover prostate cancer screening without cost-sharing (like deductibles or copays) for men aged 40-75 with specific risk factors, including family history of prostate cancer. The bill mandates that group health insurance policies (for groups over 49 people) cover annual screenings - such as digital rectal exams and PSA tests - as well as follow-up tests like imaging or lab work. This applies to all health service, hospital service, and medical service corporation contracts in New Jersey. The law affects insurance carriers by expanding existing coverage requirements and directly benefits men in the specified age group with risk factors.
S 2243 requires every public college and university in New Jersey to create a menstrual equity task force within six months of the law's effective date. The task force, appointed by each institution's president and including diverse campus stakeholders (students, faculty, housing, health centers, etc.), must develop a detailed plan for free menstrual product access within six months. The plan must cover product needs, distribution locations, costs, and a 12-month implementation timeline. Institutions must implement the approved plan within one year, ensuring equal access to menstrual products while reducing stigma. The bill defines "menstrual equity" as removing barriers to care and addressing stigma around menstruation.
